Pancreatic Cancer Research

ResearcherKorea Research Institute of Bioscience and BiotechnologyActive in the last 2 years

Boram Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7913-413X; OpenAlex author ID A5018855985. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Risk of pancreatic cancer according to glycemic status in nonalcoholic fatty liver disease: a nationwide cohort study. Co-author DOI 10.1038/s41598-025-05868-3↗
  2. A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer. Co-author DOI 10.7150/jca.50514↗
  3. Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1038/cddis.2014.558↗
  4. Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer. First author DOI 10.1007/s00280-013-2265-z↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kyungdo Han · 1 shared paper, 2025 · strength 0.23
  2. Han Na Jung · 1 shared paper, 2025 · strength 0.23
  3. Sung‐Hee Ihm · 1 shared paper, 2025 · strength 0.23
  4. Hunho Song · 2 shared papers, 2013–2021 · strength 0.14
  5. Dae Young Zang · 2 shared papers, 2013–2021 · strength 0.14
  6. Jung Han Kim · 2 shared papers, 2013–2021 · strength 0.14
  7. Jin Won Kim · 1 shared paper, 2021 · strength 0.11
  8. Byoung Yong Shim · 1 shared paper, 2021 · strength 0.11
  9. Hyunchul Jung · 1 shared paper, 2015 · strength 0.05
  10. K-H Bae · 1 shared paper, 2015 · strength 0.05
  11. Joo Young Jung · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.